Additional file 1: of MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis
Antonio Uccelli
Alice Laroni
Lou Brundin
Michel Clanet
Oscar Fernandez
Seyed Nabavi
Paolo Muraro
Roberto Oliveri
Ernst Radue
Johann Sellner
Per Soelberg Sorensen
Maria Sormani
Jens Wuerfel
Mario Battaglia
Mark Freedman
10.6084/m9.figshare.8105831.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_MEsenchymal_StEm_cells_for_Multiple_Sclerosis_MESEMS_a_randomized_double_blind_cross-over_phase_I_II_clinical_trial_with_autologous_mesenchymal_stem_cells_for_the_therapy_of_multiple_sclerosis/8105831
SPIRIT 2013 checklist: Recommended items to address in a clinical trial protocol and related documents. (DOC 256 kb)
2019-05-09 05:00:00
Multiple sclerosis
Mesenchymal stem cells
Mesenchymal stromal cells
Clinical trial